Literature DB >> 11193136

Clinical Lewy body syndromes.

I G McKeith1.   

Abstract

Lewy bodies are spherical, intracytoplasmic, eosinophilic, neuronal inclusions comprising abnormally truncated and phosphorylated intermediate neurofilament proteins, alpha-synuclein, ubiquitin, and associated enzymes. The clinical presentation of LB disease varies according to the site of LB formation and associated neuronal loss. Three main clinicopathological syndromes have been described--movement disorder, autonomic failure, and dementia. Parkinsonism is the most common presentation of LB disease developing in middle life. In older patients, a mixture of cognitive, autonomic, and motor dysfunction is more common. Dementia with LB (DLB) is a relatively recently described clinicopathological syndrome that accounts for up to 20% of all cases of dementia in old age. Patients, typically in their seventh and eighth decades, have LB pathology in cortical neurons as well as in the brain stem. LB disease should be considered in the differential diagnosis of a wide range of clinical presentations including episodic disturbances of consciousness, syncope, sleep disorders, and unexplained delirium.

Entities:  

Mesh:

Year:  2000        PMID: 11193136     DOI: 10.1111/j.1749-6632.2000.tb06898.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.

Authors:  Nozomi Hishikawa; Jun-Ichi Niwa; Manabu Doyu; Takashi Ito; Shinsuke Ishigaki; Yoshio Hashizume; Gen Sobue
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 2.  Dementia.

Authors:  James P Warner; Rob Butler; Susham Gupta
Journal:  BMJ Clin Evid       Date:  2010-04-08

Review 3.  Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Authors:  Helen E Scharfman; Andres M Kanner; Alon Friedman; Ingmar Blümcke; Candice E Crocker; Fernando Cendes; Ramon Diaz-Arrastia; Hans Förstl; André A Fenton; Anthony A Grace; Jorge Palop; Jason Morrison; Astrid Nehlig; Asuri Prasad; Karen S Wilcox; Nathalie Jette; Bernd Pohlmann-Eden
Journal:  Epilepsy Behav       Date:  2017-10-31       Impact factor: 2.937

4.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 5.  Dementia.

Authors:  Rob Butler; Raghavakurup Radhakrishnan
Journal:  BMJ Clin Evid       Date:  2012-09-10

6.  Dementia with lewy bodies in meige syndrome.

Authors:  Lap Kei Chan; Ho Yin Ho; Chi Shing Yu
Journal:  Innov Clin Neurosci       Date:  2012-07

7.  Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.

Authors:  Parvathi Rudrabhatla; Ya-Li Zheng; Niranjana D Amin; Sashi Kesavapany; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

8.  Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.

Authors:  Lorraine N Clark; Robin Chan; Rong Cheng; Xinmin Liu; Naeun Park; Nancy Parmalee; Sergey Kisselev; Etty Cortes; Paola A Torres; Gregory M Pastores; Jean P Vonsattel; Roy Alcalay; Karen Marder; Lawrence L Honig; Stanley Fahn; Richard Mayeux; Michael Shelanski; Gilbert Di Paolo; Joseph H Lee
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  Autonomic dysfunctions in parkinsonian disorders.

Authors:  Hyo-Jin Bae; Sang-Myung Cheon; Jae Woo Kim
Journal:  J Mov Disord       Date:  2009-10-30

10.  Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Authors:  Ahmad A Khundakar; Peter S Hanson; Daniel Erskine; Nichola Z Lax; Joseph Roscamp; Evangelia Karyka; Eliona Tsefou; Preeti Singh; Simon J Cockell; Andrew Gribben; Lynne Ramsay; Peter G Blain; Urs P Mosimann; Deborah J Lett; Matthias Elstner; Douglass M Turnbull; Charles C Xiang; Michael J Brownstein; John T O'Brien; John-Paul Taylor; Johannes Attems; Alan J Thomas; Ian G McKeith; Christopher M Morris
Journal:  Acta Neuropathol Commun       Date:  2016-06-30       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.